USPTO serial 79323460
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jason Paul Blair
Jason Paul Blair DYKEMA GOSSETT PLLC1301 K Street N.W.Suite 1100 WestWashington, DC 20005| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Scientific apparatus and instruments, namely, optical, isothermal, chromatographic, cardiographic, microfluidic, photometric, chemical, genetic, and biological sensors and instruments for measuring and analyzing molecular reagents, nucleic acid reagents, and immunoassay reagents for scientific testing purposes, namely, for identifying diseases or medical conditions via in vitro diagnostic (IVD) and non-in vitro diagnostic (non-IVD) applications, and for testing for specific DNA, pathogens, antigens, viruses and bacteria, none of the foregoing goods for medical diagnostic or treatment purposes; recorded software, downloadable software, and recorded and downloadable operating system software for controlling or operating and configuring biomedical sensors and instruments, analyzing test and sample results, managing assay test workflow and protocol design, and compiling and exporting medical test data for scientific, diagnostic, and medical treatment purposes; none of the foregoing used in the field of dentistry | ACTIVE | — |
| 010 | Biomedical apparatus and instruments, namely, optical, isothermal, chromatographic, cardiographic, microfluidic, photometric, chemical, genetic, and biological sensors and instruments for measuring and analyzing molecular reagents, nucleic acid reagents, and immunoassay reagents for medical purposes, namely, for identifying diseases or medical conditions via in vitro diagnostic (IVD) and non-in vitro diagnostic (non-IVD) applications, and for testing for specific DNA, pathogens, antigens, viruses and bacteria for medical diagnostic or treatment purposes; none of the foregoing used in the field of dentistry | ACTIVE | — |
| 040 | Custom manufacture of medical devices, namely, optical, isothermal, chromatographic, cardiographic, microfluidic, photometric, chemical, genetic, and biological sensors, instruments, and cartridges for measuring and analyzing molecular, nucleic acid, and immunoassay reagents using in vitro diagnostic (IVD) and non-in vitro diagnostic (non-IVD) applications for identifying diseases or medical conditions, and for testing for specific DNA, pathogens, antigens, viruses and bacteria; information, advisory and consultancy services in relation to the aforementioned; none of the foregoing used in the field of dentistry | ACTIVE | — |
| 042 | Design and development of medical devices, namely, optical, isothermal, chromatographic, cardiographic, microfluidic, photometric, chemical, genetic, and biological sensors, instruments, and cartridges for measuring and analyzing molecular reagents, nucleic acid reagents, and immunoassay reagents for medical purposes, namely, for identifying diseases or medical conditions via in vitro diagnostic (IVD) and non-in vitro diagnostic (non-IVD) applications, and for testing for specific DNA, pathogens, antigens, viruses and bacteria; design and development of computer hardware and software for controlling or operating and configuring biomedical sensors and instruments, analyzing test and sample results, managing assay test workflow and protocol design, and compiling and exporting medical test data for scientific, diagnostic, and treatment purposes; scientific research services; scientific laboratory services; medical research, analysis, and testing laboratories; none of the foregoing used in the field of dentistry | ACTIVE | — |
| 044 | Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical diagnostic testing services; information, advisory and consultancy services in relation to the aforementioned; none of the foregoing used in the field of dentistry | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| May 1, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 1, 2025 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| May 1, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 1, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 1, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 1, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 3, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 15, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 15, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 15, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 28, 2023 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Sep 10, 2023 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Aug 15, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 15, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 6, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 6, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 6, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 30, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 30, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 30, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 10, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 10, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 10, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 25, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 25, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 25, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 25, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 25, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 18, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 18, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 18, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 18, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 18, 2023 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 18, 2023 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 12, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 22, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 22, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 12, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 11, 2023 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Oct 30, 2022 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Oct 18, 2022 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 18, 2022 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 18, 2022 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 28, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 28, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 28, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 18, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 31, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 31, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 1, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 28, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 18, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 29, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 25, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 22, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |